MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 27, 2006; DOI: 10.1124/mol.106.029470


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.029470v1
71/4/959    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rovati, G.E.
Right arrow Articles by Neubig, R. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rovati, G.E.
Right arrow Articles by Neubig, R. R


Received for publication August 24, 2006.
Revised October 26, 2006.
Accepted for publication December 20, 2006.

The Highly Conserved DRY Motif of Class A GPCRs: Beyond the Ground State

G.Enrico Rovati 1*, Valerie Capra 1, Richard R Neubig 2

1 University of Milan 2 University of Michigan

* Address correspondence to: E-mail: genrico.rovati{at}unimi.it

Abstract

Despite extensive study of heptahelical G protein-coupled receptors (GPCRs), the precise mechanism of G protein activation is unknown. The role of one highly conserved stretch of residues, the amino acids Glu/Asp-Arg-Tyr, (i.e. the E/DRY motif) has received considerable attention with respect to regulating GPCR conformational states. In the consensus view, Glu/Asp maintains the receptor in its ground state, since mutations frequently induce constitutive activity (CA). This hypothesis has been confirmed by the rhodopsin ground-state crystal structure and by computational modeling approaches. However, some class A GPCRs are resistant to CA, suggesting alternative roles for the Glu/Asp residue and the E/DRY motif. Here we propose two different subgroups of receptors within class A GPCRs that make different use of the E/DRY motif, independent of the G protein type (Gs, Gi or Gq) to which the receptor couples. In P1-type receptors, non-conservative mutations of the Glu/Asp-Arg residues, besides inducing CA, increase affinity for agonist binding, retain G protein coupling, and retain an agonist-induced response. In contrast, in P2-type receptors, the E/DRY motif is more directly involved in governing receptor conformation and G protein coupling/recognition. Hence, mutations of the Glu/Asp residues do not induce CA. Conversely, non-conservative mutations of the Arg of the E/DRY motif always impair agonist-induced receptor responses and, generally, reduce agonist binding affinity. Thus, it is essential to look beyond the rhodopsin ground state model of conformational activation to clarify the role of this highly conserved triplet in GPCR activation and function.


Key words: G protein regulation, Desensitization/uncoupling, Structure-activity relationships and modeling, Prediction of structure-function/proteomics


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. L. Wacker, D. B. Feller, X.-B. Tang, M. C. DeFino, Y. Namkung, J. S. Lyssand, A. J. Mhyre, X. Tan, J. B. Jensen, and C. Hague
Disease-causing Mutation in GPR54 Reveals the Importance of the Second Intracellular Loop for Class A G-protein-coupled Receptor Function
J. Biol. Chem., November 7, 2008; 283(45): 31068 - 31078.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. A. Sarkar, I. Dodevski, M. Kenig, S. Dudli, A. Mohr, E. Hermans, and A. Pluckthun
From the Cover: Directed evolution of a G protein-coupled receptor for expression, stability, and binding selectivity
PNAS, September 30, 2008; 105(39): 14808 - 14813.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. D. Proulx, B. J. Holleran, A. A. Boucard, E. Escher, G. Guillemette, and R. Leduc
Mutational Analysis of the Conserved Asp2.50 and ERY Motif Reveals Signaling Bias of the Urotensin II Receptor
Mol. Pharmacol., September 1, 2008; 74(3): 552 - 561.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. A. Artigas, A. Gonzalez, E. Riquelme, C. A. Carvajal, A. Cattani, A. Martinez-Aguayo, A. M. Kalergis, T. Perez-Acle, and C. E. Fardella
A Novel Adrenocorticotropin Receptor Mutation Alters Its Structure and Function, Causing Familial Glucocorticoid Deficiency
J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3097 - 3105.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Pang, J. Dong, and P. Thomas
Estrogen Signaling Characteristics of Atlantic Croaker G Protein-Coupled Receptor 30 (GPR30) and Evidence It Is Involved in Maintenance of Oocyte Meiotic Arrest
Endocrinology, July 1, 2008; 149(7): 3410 - 3426.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Hase, T. Yokomizo, T. Shimizu, and M. Nakamura
Characterization of an Orphan G Protein-coupled Receptor, GPR20, That Constitutively Activates Gi Proteins
J. Biol. Chem., May 9, 2008; 283(19): 12747 - 12755.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H. Tokunaga, B. Matsuura, M. Dong, L. J. Miller, T. Ueda, S. Furukawa, Y. Hiasa, and M. Onji
Mutational analysis of predicted intracellular loop domains of human motilin receptor
Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G460 - G466.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. A. Johnston and D. P. Siderovski
Receptor-Mediated Activation of Heterotrimeric G-Proteins: Current Structural Insights
Mol. Pharmacol., August 1, 2007; 72(2): 219 - 230.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
Q. Tao, S. Nandadasa, P. D. McCrea, J. Heasman, and C. Wylie
G-protein-coupled signals control cortical actin assembly by controlling cadherin expression in the early Xenopus embryo
Development, July 15, 2007; 134(14): 2651 - 2661.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics